Order Article Reprints

Březina J, Bajer L, Wohl P, Ďuricová D, Hrabák P, Novotný A, Koželuhová J, Lukáš M, Mrázek J, Fliegerová KO, et al. Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial. Journal of Clinical Medicine. 2021; 10(13):2753. https://doi.org/10.3390/jcm10132753

Březina, Jan, Lukáš Bajer, Pavel Wohl, Dana Ďuricová, Pavel Hrabák, Aleš Novotný, Jana Koželuhová, Milan Lukáš, Jakub Mrázek, Kateřina Olša Fliegerová, and et al. 2021. "Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial" Journal of Clinical Medicine 10, no. 13: 2753. https://doi.org/10.3390/jcm10132753

Březina, J., Bajer, L., Wohl, P., Ďuricová, D., Hrabák, P., Novotný, A., Koželuhová, J., Lukáš, M., Mrázek, J., Fliegerová, K. O., Kvasnová, S., Chahrazed, M., Mareš, J., Špičák, J., & Drastich, P. (2021). Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial. Journal of Clinical Medicine, 10(13), 2753. https://doi.org/10.3390/jcm10132753